Author Response for "efficacy and Safety of Once‐weekly Semaglutide Vs Once‐daily Sitagliptin As Add‐on to Metformin in Patients with Type 2 Diabetes ( SUSTAIN China): a 30‐week Double‐blind, Phase 3a, Randomised Trial"
Diabetes Obesity and Metabolism（2020）
Key words
GLP-1 analogue,glycaemic control,incretin therapy,phase III study,randomized trial,type 2 diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined